EP1725669A1 - Methods for forming structurally defined organic molecules - Google Patents
Methods for forming structurally defined organic moleculesInfo
- Publication number
- EP1725669A1 EP1725669A1 EP05724727A EP05724727A EP1725669A1 EP 1725669 A1 EP1725669 A1 EP 1725669A1 EP 05724727 A EP05724727 A EP 05724727A EP 05724727 A EP05724727 A EP 05724727A EP 1725669 A1 EP1725669 A1 EP 1725669A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- alkyl
- combination
- group
- trypsin
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 63
- 239000000376 reactant Substances 0.000 claims abstract description 72
- 102000004157 Hydrolases Human genes 0.000 claims abstract description 66
- 108090000604 Hydrolases Proteins 0.000 claims abstract description 66
- 108090000631 Trypsin Proteins 0.000 claims description 195
- 102000004142 Trypsin Human genes 0.000 claims description 195
- 239000012588 trypsin Substances 0.000 claims description 194
- 229960001322 trypsin Drugs 0.000 claims description 193
- 238000006243 chemical reaction Methods 0.000 claims description 153
- 230000005494 condensation Effects 0.000 claims description 125
- 238000009833 condensation Methods 0.000 claims description 124
- 238000006460 hydrolysis reaction Methods 0.000 claims description 89
- 230000007062 hydrolysis Effects 0.000 claims description 84
- 229940088598 enzyme Drugs 0.000 claims description 54
- 102000004190 Enzymes Human genes 0.000 claims description 53
- 108090000790 Enzymes Proteins 0.000 claims description 53
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical group CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 51
- 125000000217 alkyl group Chemical group 0.000 claims description 45
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 41
- 108090001060 Lipase Proteins 0.000 claims description 39
- 102000004882 Lipase Human genes 0.000 claims description 39
- 239000004367 Lipase Substances 0.000 claims description 36
- 235000019421 lipase Nutrition 0.000 claims description 36
- 125000004417 unsaturated alkyl group Chemical group 0.000 claims description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 33
- 125000003118 aryl group Chemical group 0.000 claims description 33
- 108091005804 Peptidases Proteins 0.000 claims description 32
- 239000004365 Protease Substances 0.000 claims description 30
- 108010005400 cutinase Proteins 0.000 claims description 28
- 239000001257 hydrogen Chemical group 0.000 claims description 28
- 229910052739 hydrogen Inorganic materials 0.000 claims description 28
- 239000004593 Epoxy Chemical group 0.000 claims description 25
- 125000001188 haloalkyl group Chemical group 0.000 claims description 25
- 150000001412 amines Chemical group 0.000 claims description 24
- -1 aryl hydrogen Chemical group 0.000 claims description 20
- 235000019419 proteases Nutrition 0.000 claims description 19
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 14
- 125000003545 alkoxy group Chemical group 0.000 claims description 12
- 150000002431 hydrogen Chemical group 0.000 claims description 12
- 108090000371 Esterases Proteins 0.000 claims description 10
- 108050008598 Phosphoesterases Proteins 0.000 claims description 10
- 229910052710 silicon Inorganic materials 0.000 claims description 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 9
- 239000010703 silicon Substances 0.000 claims description 8
- 108010031797 Candida antarctica lipase B Proteins 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 241001661345 Moesziomyces antarcticus Species 0.000 claims description 5
- 101000968489 Rhizomucor miehei Lipase Proteins 0.000 claims description 5
- 241000209140 Triticum Species 0.000 claims description 5
- 235000021307 Triticum Nutrition 0.000 claims description 5
- 229910052732 germanium Chemical group 0.000 claims description 5
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical group [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 claims description 5
- 108090000526 Papain Proteins 0.000 claims description 4
- 102000057297 Pepsin A Human genes 0.000 claims description 4
- 229940055729 papain Drugs 0.000 claims description 4
- 235000019834 papain Nutrition 0.000 claims description 4
- 229940111202 pepsin Drugs 0.000 claims description 4
- 108090000284 Pepsin A Proteins 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 8
- AAPLIUHOKVUFCC-UHFFFAOYSA-N trimethylsilanol Chemical compound C[Si](C)(C)O AAPLIUHOKVUFCC-UHFFFAOYSA-N 0.000 description 98
- 230000000694 effects Effects 0.000 description 41
- 238000006482 condensation reaction Methods 0.000 description 40
- 230000015572 biosynthetic process Effects 0.000 description 35
- 229910001868 water Inorganic materials 0.000 description 34
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 33
- LIVNPJMFVYWSIS-UHFFFAOYSA-N silicon monoxide Inorganic materials [Si-]#[O+] LIVNPJMFVYWSIS-UHFFFAOYSA-N 0.000 description 30
- RSIHJDGMBDPTIM-UHFFFAOYSA-N ethoxy(trimethyl)silane Chemical compound CCO[Si](C)(C)C RSIHJDGMBDPTIM-UHFFFAOYSA-N 0.000 description 29
- 241000283690 Bos taurus Species 0.000 description 28
- 230000007935 neutral effect Effects 0.000 description 27
- 239000007795 chemical reaction product Substances 0.000 description 26
- 229940040461 lipase Drugs 0.000 description 25
- 102000035195 Peptidases Human genes 0.000 description 24
- 239000000758 substrate Substances 0.000 description 24
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 23
- 239000000178 monomer Substances 0.000 description 23
- 238000004817 gas chromatography Methods 0.000 description 22
- 108090000623 proteins and genes Proteins 0.000 description 22
- 235000018102 proteins Nutrition 0.000 description 21
- 102000004169 proteins and genes Human genes 0.000 description 21
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 20
- 108010027597 alpha-chymotrypsin Proteins 0.000 description 20
- 239000000047 product Substances 0.000 description 18
- SCPYDCQAZCOKTP-UHFFFAOYSA-N silanol Chemical compound [SiH3]O SCPYDCQAZCOKTP-UHFFFAOYSA-N 0.000 description 18
- 239000002609 medium Substances 0.000 description 17
- 239000013642 negative control Substances 0.000 description 17
- 238000006068 polycondensation reaction Methods 0.000 description 17
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 16
- 239000011575 calcium Substances 0.000 description 16
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 15
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 15
- 229940098773 bovine serum albumin Drugs 0.000 description 15
- 229910052791 calcium Inorganic materials 0.000 description 15
- 239000012071 phase Substances 0.000 description 15
- 239000011521 glass Substances 0.000 description 14
- 229920006395 saturated elastomer Polymers 0.000 description 14
- 230000007306 turnover Effects 0.000 description 14
- 239000012736 aqueous medium Substances 0.000 description 13
- 230000003197 catalytic effect Effects 0.000 description 13
- JJQZDUKDJDQPMQ-UHFFFAOYSA-N dimethoxy(dimethyl)silane Chemical compound CO[Si](C)(C)OC JJQZDUKDJDQPMQ-UHFFFAOYSA-N 0.000 description 13
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical compound [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 13
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 12
- 125000004122 cyclic group Chemical group 0.000 description 12
- 238000000338 in vitro Methods 0.000 description 12
- 239000003112 inhibitor Substances 0.000 description 11
- 230000005764 inhibitory process Effects 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 10
- 230000003247 decreasing effect Effects 0.000 description 10
- 230000002255 enzymatic effect Effects 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 10
- 210000000496 pancreas Anatomy 0.000 description 10
- 241000276438 Gadus morhua Species 0.000 description 9
- 229910020175 SiOH Inorganic materials 0.000 description 9
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 9
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 9
- 230000003993 interaction Effects 0.000 description 9
- CPUDPFPXCZDNGI-UHFFFAOYSA-N triethoxy(methyl)silane Chemical compound CCO[Si](C)(OCC)OCC CPUDPFPXCZDNGI-UHFFFAOYSA-N 0.000 description 9
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 8
- 102000004172 Cathepsin L Human genes 0.000 description 8
- 239000012901 Milli-Q water Substances 0.000 description 8
- 102100024078 Plasma serine protease inhibitor Human genes 0.000 description 8
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 description 8
- 239000001110 calcium chloride Substances 0.000 description 8
- 229910001628 calcium chloride Inorganic materials 0.000 description 8
- 238000006555 catalytic reaction Methods 0.000 description 8
- YQDHCCVUYCIGSW-LBPRGKRZSA-N ethyl (2s)-2-benzamido-5-(diaminomethylideneamino)pentanoate Chemical compound NC(=N)NCCC[C@@H](C(=O)OCC)NC(=O)C1=CC=CC=C1 YQDHCCVUYCIGSW-LBPRGKRZSA-N 0.000 description 8
- 230000036961 partial effect Effects 0.000 description 8
- 102000004196 processed proteins & peptides Human genes 0.000 description 8
- 108090000765 processed proteins & peptides Proteins 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 8
- 108090000624 Cathepsin L Proteins 0.000 description 7
- 238000004925 denaturation Methods 0.000 description 7
- 230000036425 denaturation Effects 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- YFCUZWYIPBUQBD-ZOWNYOTGSA-N n-[(3s)-7-amino-1-chloro-2-oxoheptan-3-yl]-4-methylbenzenesulfonamide;hydron;chloride Chemical compound Cl.CC1=CC=C(S(=O)(=O)N[C@@H](CCCCN)C(=O)CCl)C=C1 YFCUZWYIPBUQBD-ZOWNYOTGSA-N 0.000 description 7
- 229920001184 polypeptide Polymers 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 244000068988 Glycine max Species 0.000 description 6
- 235000010469 Glycine max Nutrition 0.000 description 6
- 101710120260 Silicatein Proteins 0.000 description 6
- 229920006362 Teflon® Polymers 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 6
- 238000011208 chromatographic data Methods 0.000 description 6
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 6
- 238000003760 magnetic stirring Methods 0.000 description 6
- 229920000729 poly(L-lysine) polymer Polymers 0.000 description 6
- 239000000377 silicon dioxide Substances 0.000 description 6
- MQUQNUAYKLCRME-INIZCTEOSA-N N-tosyl-L-phenylalanyl chloromethyl ketone Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N[C@H](C(=O)CCl)CC1=CC=CC=C1 MQUQNUAYKLCRME-INIZCTEOSA-N 0.000 description 5
- 230000004913 activation Effects 0.000 description 5
- 239000008346 aqueous phase Substances 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 238000006911 enzymatic reaction Methods 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 238000012552 review Methods 0.000 description 5
- 238000007151 ring opening polymerisation reaction Methods 0.000 description 5
- CWUHERHJSPPFHQ-UHFFFAOYSA-N 2,2-dimethyloxasilinane Chemical compound C[Si]1(C)CCCCO1 CWUHERHJSPPFHQ-UHFFFAOYSA-N 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 4
- 108090000317 Chymotrypsin Proteins 0.000 description 4
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 4
- 239000004472 Lysine Substances 0.000 description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
- 229960002376 chymotrypsin Drugs 0.000 description 4
- ZYTXJPZTWXLTJC-UHFFFAOYSA-N diethoxy(diethyl)germane Chemical compound CCO[Ge](CC)(CC)OCC ZYTXJPZTWXLTJC-UHFFFAOYSA-N 0.000 description 4
- TUEYHEWXYWCDHA-UHFFFAOYSA-N ethyl 5-methylthiadiazole-4-carboxylate Chemical compound CCOC(=O)C=1N=NSC=1C TUEYHEWXYWCDHA-UHFFFAOYSA-N 0.000 description 4
- 108010074605 gamma-Globulins Proteins 0.000 description 4
- 238000000769 gas chromatography-flame ionisation detection Methods 0.000 description 4
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 241000228245 Aspergillus niger Species 0.000 description 3
- 208000035404 Autolysis Diseases 0.000 description 3
- 241000589513 Burkholderia cepacia Species 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 206010057248 Cell death Diseases 0.000 description 3
- 229940122644 Chymotrypsin inhibitor Drugs 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 3
- 102100037611 Lysophospholipase Human genes 0.000 description 3
- 241000498617 Mucor javanicus Species 0.000 description 3
- RSYYQCDERUOEFI-JTQLQIEISA-N N-benzoyl-L-arginine Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)C1=CC=CC=C1 RSYYQCDERUOEFI-JTQLQIEISA-N 0.000 description 3
- 108010067372 Pancreatic elastase Proteins 0.000 description 3
- 102000016387 Pancreatic elastase Human genes 0.000 description 3
- 108050006759 Pancreatic lipases Proteins 0.000 description 3
- 102000019280 Pancreatic lipases Human genes 0.000 description 3
- 240000000064 Penicillium roqueforti Species 0.000 description 3
- 235000002233 Penicillium roqueforti Nutrition 0.000 description 3
- 108010058864 Phospholipases A2 Proteins 0.000 description 3
- 101001003495 Pseudomonas fluorescens Lipase Proteins 0.000 description 3
- 101001064559 Pseudomonas fluorescens Lipase Proteins 0.000 description 3
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 3
- 102000018690 Trypsinogen Human genes 0.000 description 3
- 108010027252 Trypsinogen Proteins 0.000 description 3
- 241000482268 Zea mays subsp. mays Species 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003541 chymotrypsin inhibitor Substances 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 3
- ZVJXKUWNRVOUTI-UHFFFAOYSA-N ethoxy(triphenyl)silane Chemical compound C=1C=CC=CC=1[Si](C=1C=CC=CC=1)(OCC)C1=CC=CC=C1 ZVJXKUWNRVOUTI-UHFFFAOYSA-N 0.000 description 3
- HHBOIIOOTUCYQD-UHFFFAOYSA-N ethoxy-dimethyl-[3-(oxiran-2-ylmethoxy)propyl]silane Chemical compound CCO[Si](C)(C)CCCOCC1CO1 HHBOIIOOTUCYQD-UHFFFAOYSA-N 0.000 description 3
- FIHCECZPYHVEJO-UHFFFAOYSA-N ethoxy-dimethyl-phenylsilane Chemical compound CCO[Si](C)(C)C1=CC=CC=C1 FIHCECZPYHVEJO-UHFFFAOYSA-N 0.000 description 3
- 230000002538 fungal effect Effects 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000006225 natural substrate Substances 0.000 description 3
- 229940116369 pancreatic lipase Drugs 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000005191 phase separation Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 230000028043 self proteolysis Effects 0.000 description 3
- 229910000077 silane Inorganic materials 0.000 description 3
- 150000004756 silanes Chemical class 0.000 description 3
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 3
- 235000012239 silicon dioxide Nutrition 0.000 description 3
- 150000003384 small molecules Chemical class 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- 239000013638 trimer Substances 0.000 description 3
- DLOSDQIBVXBWTB-UHFFFAOYSA-N 1-[dimethyl(propyl)silyl]oxyethanamine Chemical compound CCC[Si](C)(C)OC(C)N DLOSDQIBVXBWTB-UHFFFAOYSA-N 0.000 description 2
- MCTWTZJPVLRJOU-UHFFFAOYSA-N 1-methyl-1H-imidazole Chemical compound CN1C=CN=C1 MCTWTZJPVLRJOU-UHFFFAOYSA-N 0.000 description 2
- 239000004925 Acrylic resin Substances 0.000 description 2
- 229920000178 Acrylic resin Polymers 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 241000219173 Carica Species 0.000 description 2
- 235000009467 Carica papaya Nutrition 0.000 description 2
- 241000195957 Equisetum telmateia Species 0.000 description 2
- 108010044091 Globulins Proteins 0.000 description 2
- 102000006395 Globulins Human genes 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- 241000223792 Paramecium tetraurelia Species 0.000 description 2
- 241000243142 Porifera Species 0.000 description 2
- 102000012479 Serine Proteases Human genes 0.000 description 2
- 108010022999 Serine Proteases Proteins 0.000 description 2
- 229910018557 Si O Inorganic materials 0.000 description 2
- 108010056079 Subtilisins Proteins 0.000 description 2
- 102000005158 Subtilisins Human genes 0.000 description 2
- 241000769134 Tethya aurantium Species 0.000 description 2
- 229940122618 Trypsin inhibitor Drugs 0.000 description 2
- 101710162629 Trypsin inhibitor Proteins 0.000 description 2
- 241000235015 Yarrowia lipolytica Species 0.000 description 2
- 230000002152 alkylating effect Effects 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 229920001222 biopolymer Polymers 0.000 description 2
- SIOVKLKJSOKLIF-UHFFFAOYSA-N bis(trimethylsilyl)acetamide Chemical compound C[Si](C)(C)OC(C)=N[Si](C)(C)C SIOVKLKJSOKLIF-UHFFFAOYSA-N 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- 238000000132 electrospray ionisation Methods 0.000 description 2
- SRLROPAFMUDDRC-INIZCTEOSA-N ethyl N-benzoyl-L-tyrosinate Chemical compound C([C@@H](C(=O)OCC)NC(=O)C=1C=CC=CC=1)C1=CC=C(O)C=C1 SRLROPAFMUDDRC-INIZCTEOSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- HTDJPCNNEPUOOQ-UHFFFAOYSA-N hexamethylcyclotrisiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O1 HTDJPCNNEPUOOQ-UHFFFAOYSA-N 0.000 description 2
- HNVBZKNIPZVUDV-UHFFFAOYSA-N hexoxy(trimethyl)silane Chemical compound CCCCCCO[Si](C)(C)C HNVBZKNIPZVUDV-UHFFFAOYSA-N 0.000 description 2
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 2
- 238000012643 polycondensation polymerization Methods 0.000 description 2
- 238000009790 rate-determining step (RDS) Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- CMQCNTNASCDNGR-UHFFFAOYSA-N toluene;hydrate Chemical compound O.CC1=CC=CC=C1 CMQCNTNASCDNGR-UHFFFAOYSA-N 0.000 description 2
- 239000002753 trypsin inhibitor Substances 0.000 description 2
- HNGIZKAMDMBRKJ-LBPRGKRZSA-N (2S)-2-acetamido-3-(1H-indol-3-yl)propanamide Chemical compound C1=CC=C2C(C[C@H](NC(=O)C)C(N)=O)=CNC2=C1 HNGIZKAMDMBRKJ-LBPRGKRZSA-N 0.000 description 1
- XOVNCWWRDSAYNE-UHFFFAOYSA-N 2,4,6,8-tetramethyl-2,4,6,8-tetrakis(3,3,3-trifluoropropyl)-1,3,5,7,2,4,6,8-tetraoxatetrasilocane Chemical compound FC(F)(F)CC[Si]1(C)O[Si](C)(CCC(F)(F)F)O[Si](C)(CCC(F)(F)F)O[Si](C)(CCC(F)(F)F)O1 XOVNCWWRDSAYNE-UHFFFAOYSA-N 0.000 description 1
- IRVZFACCNZRHSJ-UHFFFAOYSA-N 2,4,6,8-tetramethyl-2,4,6,8-tetraphenyl-1,3,5,7,2,4,6,8-tetraoxatetrasilocane Chemical compound O1[Si](C)(C=2C=CC=CC=2)O[Si](C)(C=2C=CC=CC=2)O[Si](C)(C=2C=CC=CC=2)O[Si]1(C)C1=CC=CC=C1 IRVZFACCNZRHSJ-UHFFFAOYSA-N 0.000 description 1
- URZHQOCYXDNFGN-UHFFFAOYSA-N 2,4,6-trimethyl-2,4,6-tris(3,3,3-trifluoropropyl)-1,3,5,2,4,6-trioxatrisilinane Chemical compound FC(F)(F)CC[Si]1(C)O[Si](C)(CCC(F)(F)F)O[Si](C)(CCC(F)(F)F)O1 URZHQOCYXDNFGN-UHFFFAOYSA-N 0.000 description 1
- GLISOBUNKGBQCL-UHFFFAOYSA-N 3-[ethoxy(dimethyl)silyl]propan-1-amine Chemical compound CCO[Si](C)(C)CCCN GLISOBUNKGBQCL-UHFFFAOYSA-N 0.000 description 1
- XPRFEQVJCFQSMB-UHFFFAOYSA-N 4-[hydroxy(dimethyl)silyl]butan-1-ol Chemical compound C[Si](C)(O)CCCCO XPRFEQVJCFQSMB-UHFFFAOYSA-N 0.000 description 1
- ZNYRFEPBTVGZDN-UHFFFAOYSA-N 5S,6S-epoxy-15R-hydroxy-ETE Chemical compound COCCOCCOCCOCCO ZNYRFEPBTVGZDN-UHFFFAOYSA-N 0.000 description 1
- 102000035101 Aspartic proteases Human genes 0.000 description 1
- 108091005502 Aspartic proteases Proteins 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 102000006734 Beta-Globulins Human genes 0.000 description 1
- 108010087504 Beta-Globulins Proteins 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 102000003670 Carboxypeptidase B Human genes 0.000 description 1
- 102100035024 Carboxypeptidase B Human genes 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 101710137926 Chymotrypsin inhibitor Proteins 0.000 description 1
- 241000206750 Cylindrotheca fusiformis Species 0.000 description 1
- 102000005927 Cysteine Proteases Human genes 0.000 description 1
- 108010005843 Cysteine Proteases Proteins 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 101000946524 Homo sapiens Carboxypeptidase B Proteins 0.000 description 1
- 238000004971 IR microspectroscopy Methods 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 238000003109 Karl Fischer titration Methods 0.000 description 1
- 108010075530 Kunitz Soybean Trypsin Inhibitor Proteins 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 101710098556 Lipase A Proteins 0.000 description 1
- 101710099648 Lysosomal acid lipase/cholesteryl ester hydrolase Proteins 0.000 description 1
- 102100026001 Lysosomal acid lipase/cholesteryl ester hydrolase Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 108010084311 Novozyme 435 Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- HMDDXIMCDZRSNE-UHFFFAOYSA-N [C].[Si] Chemical compound [C].[Si] HMDDXIMCDZRSNE-UHFFFAOYSA-N 0.000 description 1
- SNAOERCFXOQPFV-UHFFFAOYSA-M [OH-].[K+].[K+].[K+].OB([O-])[O-].OC(O)=O Chemical compound [OH-].[K+].[K+].[K+].OB([O-])[O-].OC(O)=O SNAOERCFXOQPFV-UHFFFAOYSA-M 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000007171 acid catalysis Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-L aspartate group Chemical group N[C@@H](CC(=O)[O-])C(=O)[O-] CKLJMWTZIZZHCS-REOHCLBHSA-L 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000005815 base catalysis Methods 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000003592 biomimetic effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- JJRDHFIVAPVZJN-UHFFFAOYSA-N cyclotrisiloxane Chemical compound O1[SiH2]O[SiH2]O[SiH2]1 JJRDHFIVAPVZJN-UHFFFAOYSA-N 0.000 description 1
- FRUYFVRBAVJUOB-UHFFFAOYSA-N diethoxy(diethyl)germane Chemical compound CCO[Ge](CC)(CC)OCC.CCO[Ge](CC)(CC)OCC FRUYFVRBAVJUOB-UHFFFAOYSA-N 0.000 description 1
- 229960004132 diethyl ether Drugs 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000000119 electrospray ionisation mass spectrum Methods 0.000 description 1
- 238000002149 energy-dispersive X-ray emission spectroscopy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- CWAFVXWRGIEBPL-UHFFFAOYSA-N ethoxysilane Chemical class CCO[SiH3] CWAFVXWRGIEBPL-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- NVLSQUHZYABYHJ-UHFFFAOYSA-N hydroxy(trimethyl)silane;trimethyl(trimethylsilyloxy)silane Chemical compound C[Si](C)(C)O.C[Si](C)(C)O[Si](C)(C)C NVLSQUHZYABYHJ-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 125000000741 isoleucyl group Chemical group [H]N([H])C(C(C([H])([H])[H])C([H])([H])C([H])([H])[H])C(=O)O* 0.000 description 1
- 229960004592 isopropanol Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- IWZKICVEHNUQTL-UHFFFAOYSA-M potassium hydrogen phthalate Chemical compound [K+].OC(=O)C1=CC=CC=C1C([O-])=O IWZKICVEHNUQTL-UHFFFAOYSA-M 0.000 description 1
- 230000003334 potential effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 150000004819 silanols Chemical class 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 238000006884 silylation reaction Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- IGHGOYDCVRUTSU-UHFFFAOYSA-M sodium;2-hydroxypropane-1,2,3-tricarboxylic acid;hydroxide Chemical compound [OH-].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O IGHGOYDCVRUTSU-UHFFFAOYSA-M 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000006250 specific catalysis Methods 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 238000001757 thermogravimetry curve Methods 0.000 description 1
- UHUUYVZLXJHWDV-UHFFFAOYSA-N trimethyl(methylsilyloxy)silane Chemical compound C[SiH2]O[Si](C)(C)C UHUUYVZLXJHWDV-UHFFFAOYSA-N 0.000 description 1
- MOOOYQDIYFVYGD-UHFFFAOYSA-J tripotassium;sodium;hydroxide;phosphate Chemical compound [OH-].[Na+].[K+].[K+].[K+].[O-]P([O-])([O-])=O MOOOYQDIYFVYGD-UHFFFAOYSA-J 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P9/00—Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen
Definitions
- the present invention relates to methods for forming organic molecules, and more particularly, to methods for forming organic molecules comprising contacting a hydrolase enzyme with an organic reactant.
- the present invention is directed to methods of forming an organic molecule.
- the method comprises contacting a hydrolase enzyme with an organic reactant.
- the organic reactant comprises the formula:
- X is selected from the group consisting of silicon and germanium;
- R 1 is selected from the group consisting of alkyl, haloalkyl, unsaturated alkyl, aryl, alcohol, epoxy, ether, amine, -(OXR 4 2 ) y -OXR 4 3 and a combination thereof;
- R 2 is selected from the group consisting of alkyl, hydrogen, ether and a combination thereof;
- R 3 is selected from the group consisting of alkyl, unsaturated alkyl, aryl, hydrogen and a combination thereof;
- R 4 is selected from the group consisting of alkyl, haloalkyl, unsaturated alkyl, aryl, hydrogen, hydroxy, alkoxy, alcohol, epoxy, ether, amine, -(0?XR 4 2 ) y -OXR 4 3 and a combination thereof;
- n is an integer from 0 to 4;
- y is 0 or is an integer greater than 0; and
- a method of forming an organosilicon molecule comprises contacting a hydrolase enzyme with an organosilicon reactant.
- the organosilicon reactant comprises the formula:
- R 1 is selected from the group consisting of alkyl, haloalkyl, unsaturated alkyl, aryl, alcohol, epoxy, ether, amine, -(OSiR 4 2 ) y -OSiR 4 3 , and a combination thereof
- R 2 is selected from the group consisting of alkyl, hydrogen, ether and a combination thereof
- R 3 is selected from the group consisting of alkyl, unsaturated alkyl, aryl, hydrogen and a combination thereof
- R 4 is selected from the group consisting of alkyl, haloalkyl, unsaturated alkyl, aryl, hydrogen, hydroxy, alkoxy, alcohol, epoxy, ether, amine, - (OSiR )y-OSiR 4 3 and a combination thereof
- n is an integer from 0 to 4
- y is 0 or an integer greater than 0
- z is 3 or is an integer greater than 3.
- the hydrolase enzyme comprises lipase, protease, phosphoesterase, esterase, cutinase or a combination thereof.
- the hydrolase enzyme catalyzes the hydrolysis and condensation of the organosilicon reactant to form the organosilicon molecule.
- a met?hod of forming an organosilicon intermediate molecule comprises contacting a hydrolase enzyme with an organosilicon reactant.
- the organosilicon reactant comprises the formula: (R 1 ) 4 . n Si(OR 2 ) n or R V 3/ o or
- R is selected from the group consisting of alkyl, haloalkyl, unsaturated alkyl, aryl, alcohol, epoxy, ether, amine, -(OSiR 4 2 ) y -OSiR 4 3 , and a combination thereof;
- R 2 is selected from the group consisting of alkyl, hydrogen, ether and a combination thereof;
- R 3 is selected from the group consisting of alkyl, unsaturated alkyl, aryl, hydrogen and a combination thereof;
- R 4 is selected from the group consisting of alkyl, haloalkyl, unsaturated alkyl, aryl, hydrogen, hydroxy, aikoxy, alcohol, epoxy, ether, amine, - (OSiR 4 2 )y-OSiR 4 3 and a combination thereof;
- n is an integer from 0 to 4;
- y is 0 or is an integer greater than 0;
- z is 3 or is an integer greater than 3.
- the hydrolase enzyme comprises lipase, protease, phosphoesterase, esterase, cutinase or a combination thereof.
- the hydrolase enzyme catalyzes the hydrolysis of the organosilicon reactant to form the organosilicon intermediate molecule.
- a method of forming an organosilicon molecule comprises contacting a hydrolase enzyme with an organosilicon intermediate reactant.
- the organosilicon intermediate reactant comprises the formula:
- R 1 is selected from the group consisting of alkyl, haloalkyl, unsaturated alkyl, aryl, alcohol, epoxy, ether, amine, -(OSiR 4 ) y -OSiR 4 3 , and combination thereof;
- R 2 is a hydrogen;
- R 4 is selected from the group consisting of alkyl, haloalkyl, unsaturated alkyl, aryl, hydrogen, hydroxy, alkoxy, alcohol, epoxy, ether, amine, -(OSiR 4 2 ) y -OSiR 4 3 and a combination thereof;
- n is an integer from 0 to 4; and
- y is 0 or is an integer greater than 0;
- a + b equals z; and
- z is 3 or is an integer greater than 3.
- the hydrolase enzyme comprises lipase, protease, phosphoesterase, esterase, cutinase or a combination thereof.
- the hydrolase enzyme catalyzes the condensation of the organosilicon intermediate reactant to form the organosilicon molecule.
- FIG. 1 illustrates the primary structure of trypsinogen
- FIG. 2 illustrates the activation of trypsinogen
- FIG. 3 illustrates a GC-FID chromatogram of a trimethylethoxysilane negative control reaction
- FIG. 4 illustrates a protease-catalyzed condensation study after three hours
- FIG. 5 illustrates the condensation control reactions after three hours
- FIG. 6 illustrates ⁇ -chymotrypsin and trypsin impurity study
- FIG. 7 illustrates a proteinaceous inhibition of the condensation of trimethylsilanol
- FIG. 8 illustrates the effect of temperature on the tryp sin-catalyzed condensation of trimethylsilanol
- FIG. 9 illustrates a study of the thermal denaturation of trypsin in neutral media as a function of the concentration of trypsin
- FIG. 10 illustrates trypsin-catalyzed condensation of trimethylsilanol at 25 °C
- FIG. 11 illustrates saturated-trimethylsilanol to trypsin mole ratio study
- FIG. 12 illustrates the autolysis of trypsin at 25°C
- FIG. 13 illustrates the proposed reaction mechanism of trypsin-catalyzed condensation of trimethylsilanol
- FIG. 14 illustrates a pH study of the activity of different tryptic species
- FIG. 15 illustrates the effect of pH on the trypsin-catalyzed condensation of trimethylsilanol
- FIG. 16 illustrates the effect of trimethylsilanol and pH on trypsin activity
- FIG. 17 illustrates the hydrolysis and condensation control reactions after three hours
- FIG. 18 illustrates trypsin-catalyzed hydrolysis and condensation of trimethylethoxysilane at 10 ° C;
- FIG. 19 illustrates turnover numbers of the trypsin-catalyzed hydrolysis of trimethylethoxysilane and condensation of trimethylsilanol at 10 C;
- FIG. 20 illustrates trypsin-catalyzed hydrolysis and condensation of trimethylalkoxysilanes
- FIG. 21 illustrates trypsin-catalyzed hydrolysis and condensation of ethoxysilanes
- FIG. 22 illustrates trypsin-catalyzed hydrolysis and condensation of 1,1-dimethyl- 1 -sila-2-oxacyclohexane
- FIG. 23 illustrates proteinaceous inhibition of the trimethylethoxysilane reaction
- FIG. 24 illustrates the hydrolysis and condensation of trimethylethoxysilane by different sources of trypsin
- FIG. 25 illustrates the effect of calcium on the trypsin-catalyzed condensation of trimethylsilanol
- FIG. 26 illustrates the cutinase-catalyzed condensation of trimethylsilanol at 25° C after 14 hours;
- the study of hydrolysis and condensation reactions in fonning organic molecules is complicated. Specifically, such reactions are complicated in biosilicification due to the enhanced sensitivity of silica, silicates, and silicic acid to pH, concentration and temperature. Accordingly, the present invention overcomes such complications by utilizing a hydrolase enzyme to form structurally defined organic and more specifically organosilicon molecules.
- the hydrolase enzyme non-specifically promotes the hydrolysis of the organic reactant (A) to form an organic intermediate reactant (B) and subsequently selectively catalyzes the condensation of the organic intermediate reactant (B) to form the organic molecule (C).
- the organic reactants (A) of Reactions (I), (II) and (III) are acceptable substrates for the hydrolase enzyme to selectively catalyze hydrolysis and condensation of the organic reactant.
- the reactive sites of the organic reactant (A) comprise an electropositive atom (e.g. silicon or germanium) which facilitates the hydrolysis and condensation of the organic reactant (A) to ultimately form the organic molecule (C).
- structurally defined organic molecules may be formed using the organic reactants (A) of Reactions (I), (II) and (III).
- R 1 is selected from the group consisting of alkyl, haloalkyl, unsaturated alkyl, aryl, alcohol, epoxy, ether, amine, -(O)CR 4 2 ) y -OXR 4 , and a combination thereof, wherein R 4 is selected from the group consisting of alkyl, haloalkyl, unsaturated alkyl, aryl, hydrogen, hydroxy, alkoxy, alcohol, epoxy, ether, amine, -(OXR 4 2 ) y -OXR 4 3 and a combination thereof.
- R 2 is selected from the group consisting of alkyl, hydrogen, ether and a combination thereof.
- R 3 is selected from the group consisting of alkyl, unsaturated alkyl, aryl and hydrogen.
- alkyl, haloalkyl, unsaturated alkyl, and alkoxy may be substituents having one carbon or more than one carbon.
- n is defined as an integer from 0 to 4; y is defined as 0 or as an integer greater than 0; and z is 3 or an integer greater than 3.
- * as used throughout the application is indicative of a cyclic architecture, i.e., there is no defined end group.
- the organic reactant (A) may be monofunctional or polyfunctional.
- the formula of the organic reactant (A) may be selected from the group consisting of (R 1 ) 4 X, (R 1 ) 3 X(OR 2 ) ⁇ , (R l )2X(OR 2 ) 2 , (R 1 ) ⁇ X(OR 2 ) 3 and X(OR 2 ) 4 .
- di-functional organic reactants include, but are not limited to, (CH 3 ) 2 Si(OCH 3 )2, (CH 3 )(CF 3 CH 2 CH 2 )Si(OCH 3 ) 2 . (C 6 H 5 )(CH 3 )Si(OCH 3 ) 2 , and (CH 3 CH 2 ) 2 Ge(OCH 2 CH 3 ) 2 .
- tri- and tetra- functional organic reactants include, but are not limited to, (CH 3 )Si(OCH 2 CH 3 ) 3 and Si(OCH 2 CH 3 ) 4 , respectively.
- the organic reactant may also be linear, branched, resinous, or cyclic. In one embodiment, the distributions of linear, cyclic, and branched organic molecules may be fully hydroxy lated after the initial interaction with the hydrolase enzyme.
- cyclic, linear, and branched organic reactants include, but are not limited to, l,3,5,7-tetramethyl-l,3,5,7-tetramethoxy- cyclotetrasiloxane, l,3-bis(hydroxy)tetramethyldisiloxane, and [(HO) 2 (CH 3 )SiO] 3 SiCH 3 , respectively.
- the organic reactant is contacted with a hydrolase enzyme in order to catalyze the formation of an organic molecule.
- the hydrolase enzyme may be derived from a bacterial, fungal, or mammalian source, or the hydrolase enzyme may be derived from any other suitable source.
- the enzyme is generally present as either a soluble solution or a heterogeneous suspension, and the enzyme may be lyophilized or immobilized.
- the hydrolase enzyme is selected from the group consisting of lipase, protease, phosphoesterase, esterase, cutinase and a combination thereof.
- the hydrolase enzyme comprises a lipase enzyme such as Candida antarctica lipase, Candida antarctica lipase B, Rhizomucor miehei lipase, wheat germ lipase or a combination thereof
- the hydrolase enzyme comprises a protease enzyme such as trypsin, papain, pepsin or a combination thereof.
- the hydrolase enzyme is trypsin or an enzyme that is at least 70% homologous with trypsin.
- Trypsinogen (FIGS. 1-2) is activated following the hydrolysis of the Lys6-Ile7 peptide bond and formation of ⁇ -trypsin (i.e. a disulfide cross- linked single polypeptide chain). Hydrophobic interactions with the new N-terminal isoleucine residue lead to the formation of regions such as the binding domain and oxyanion hole, which are known to participate in substrate recognition. As defined by these regions, trypsin selectively hydrolyses peptide bonds adjacent to basic residues (i.e. arginine > lysine » natural amino acids).
- ⁇ -trypsin i.e. a cross-linked two-chain structure
- pseudotrypsin i.e. a cross-linked three-chain structure
- the activation reactions and structural changes cause negligible alterations to the region of the catalytic triad (i.e. Serl83-His46-Aspl77, FIG. 1 and SEQ ID NO:l). Based on these regions, trypsin has an affinity for basic residues in the substrate such as arginine and lysine due to an electrostatic attraction with an aspartate residue at the bottom of the pocket.
- trypsin contain a mixture of predominately ⁇ - and ⁇ -trypsin as well as other digestive enzymatic contaminates. Based on the primary structure, the molecular weight of trypsin is 23,305. Furthermore, calcium may be added to the reaction to assist the hydrolase enzyme in reaction activity and specifically to promote stability of the enzyme.
- the concentration, temperature and pH of the reaction may be varied as set forth in detail below. Specifically, the concentration of the hydrolase enzyme is generally greater than 1 mg/mL. In another embodiment, the concentration of the hydrolase enzyme is from about 10 mg/mL to about 80 mg/mL. In yet another embodiment, the concentration of the hydrolase enzyme is from about 20 mg/mL to about 60 mg/mL. In yet another embodiment, the concentration of the hydrolase enzyme is about 40 mg/mL. In one embodiment, the organic reactant to enzyme mole ratio is less than or equal to about 40000:1. hi another embodiment, the organic reactant to enzyme mole ratio is less than or equal to about 1000:1.
- the temperature of the reactions is generally between about 5°C and 90°C. In another embodiment, the reaction is carried out at a temperature of between about 20°C to about 50°C. In yet another embodiment, the reaction is carried out at a temperature about 25°C.
- the pH of the reaction is generally from about 5.0 to about 8.0. In one embodiment, the pH of the reaction is about 7.0.
- the reactions may be performed under solventless (neat) conditions, or the reactions may be performed utilizing an aqueous solution or a solvent.
- Suitable solvents include, but are not limited to, water miscible organic solvent such as THF and acetonitrile, and relatively dry organic solvents such as toluene and hexane.
- Aspergillus niger lipase (Amano lipase A, #53,478-1), N- ⁇ -benzoyl-L-arginine ethyl ester (BAEE, #B4500), N-benzoyl-L-tyrosine ethyl ester (BTEE, #B6125), bovine pancreatic ⁇ -chymotrypsin (#C-4129), bovine pancreatic ⁇ -chymotrypsin treated with TLCK (#C3142), bovine pancreatic phospho lipase A2 (P-8913), bovine pancreatic trypsin (#T4665), bovine pancreatic trypsin treated with TPCK (#T1426), bovine serum albumin (BSA, #B4287), Candida antarctica lipase (#62299), Candida lipolytica lipase (#62303), Gadus morhua trypsin (#T9906), hog stomach pepsin (
- Bovine kidney cathepsin L (#219418), human liver cathepsin L (#219402), and Paramecium tetraurelia cathepsin L (#219412) were purchased from Calbiochem®, EMD Biosciences (San Diego, CA). Recombinant bovine trypsin expressed in maize (#TRY, CAS #9002-07-7) was purchased from Prodi Gene (College Station, TX). The cutinase variant was provided by Genencor International, Inc. (Palo Alto, CA).
- Trizma® pre-set crystals pH 7.0 (Tris-HCl, #T3503), pH 7.5 (Tris-HCl, #T4128), pH 7.8 (Tris-HCl, #T4503), pH 8.0 (Tris-HCl, #T4753), and pH 9.0 (Tris-HCl, #T6003) were purchased from Sigma-Aldrich.
- Buffer solutions pH 4.00 (potassium biphthalate, #SB101), pH 5 (sodium hydroxide-citric acid, #A015860101), pH 6.00 (monobasic potassium phosphate-sodium hydroxide, #SB104), and pH 10.00 (potassium carbonate-potassium borate-potassium hydroxide, #SB115) were purchased at Fisher Scientific (Pittsburgh, PA). Or anic and Inorganic Molecules
- Acetonitrile (#A996-4), acetone (#A929-4), phosphorous pentoxide (#A244), 2- propanol (#A451-4), tetrahydrofuran (#T427-1), and toluene (#T291-4) were purchased from Fisher Scientific.
- Acetic acid (#A6283), calcium chloride (#C3881), dodecane (#44010), ethanol (#45,984-4), hexanol (#H13303), hydrochloric acid (#33,925-3), lithium aluminum hydride (#19,987-7), sodium chloride (#20,443-9), and sodium hydrogencarbonate (#34,094-4) were purchased from Sigma-Aldrich.
- Tetraethylene glycol monomethyl ether (#T1372) was purchased from TCI America (Portland, OR). Diethyldiethoxygermane (#GED 3404.2) was purchased at Gelest, Inc. (Tullytown, PA). HPLC grade organic solvents were used throughout the examples
- Trimethylsilanol (CAS #1066-40-6, #12848-72), heptamethylhydroxytetracyclosiloxane (#11050-134B), hexamethylcyclotrisiloxane (#E- 459-80, cut #3), octamethylcyclotetrasiloxane (#E- 1927-93 -2, lot #2), 1,3,5-trimethyl- l,3,5-tri(3,3,3-trifluoropropyl)cyclotrisiloxane (LS Trimer), l,3,5,7-tetramethyl-l,3,5,7- tetra(3,3,3-trifluoropropyl)cyclotetrasiloxane (#H-1387-145), and 2,4,6,8-trimethyl- 2,4,6, 8-tetraphenyl-cyclotetrasiloxane (#1923-44A) were obtained at the Dow Corning Corporation.
- 3-Aminopropyldimethylethoxysilane (#SIA0603.0), bis(trimethylsilyl)acetamide (#SIB1846.0), dimethyldimethoxysilane (#SID 4123.0), 1,1- dimethyl- l-sila-2-oxacyclohexane (#SID4234.0), 3-glycidoxypropyldimethylethoxysilane (#SIG5825), hexamethyldisiloxane (#SIH6115.0), trimethylethoxysilane (#SIT8515.0), and triphenylethoxysilane (#SIT8652.0) were purchased at Gelest, Inc. (Tullytown, PA).
- Hexamethyldisilazane (#37921-2) and tetraethoxysilane (#23620-9) were purchased at Sigma-Aldrich.
- Phenyldimethylethoxysilane (#P0161) was purchased from United Chemical Technologies, Inc. (Bristol, PA).
- Methyltriethoxysilane (#M9050) was purchased from Huls America, Inc. (Bristol, PA).
- Tetraethylene glycol monomethyl ether (TGME) and hexanol were silylated with bis(trimethylsilyl)acetamide to obtain the target polar (Me 3 SiO(CH 2 CH 2 O) 4 CH 3 ) and non- polar (Me 3 SiOC 6 H ⁇ 3 ) silanes, respectively.
- TGME Tetraethylene glycol monomethyl ether
- hexanol were silylated with bis(trimethylsilyl)acetamide to obtain the target polar (Me 3 SiO(CH 2 CH 2 O) 4 CH 3 ) and non- polar (Me 3 SiOC 6 H ⁇ 3 ) silanes, respectively.
- the measure of extraction efficiency was defined as the percent yield of reactants and products.
- the mass balances were equal to the sum total of the extraction values.
- the response factors for the analytes were calculated and determined to be linear as a function of concentration over three orders of magnitude (i.e. 0.1-10% (w/w)).
- the alkoxysilane, silanol, and disiloxane analytes were chromato graphically resolved as illustrated in FIG. 3.
- the ability to resolve these analytes was necessary to differentiate between the role of an enzyme in the hydrolysis and condensation reactions during biosilicification.
- Tethya aurantia marine sponge i.e. silicatein
- Equisetum telmateia plant i.e. biopolymer
- This study was directed to an enzyme screen with trimethylsilanol in order to evaluate the ability of various enzymes to catalyze the formation of a siloxane bond.
- a series of lipases and serine-proteases were selected as homologous proteolytic enzymes.
- the active sites in the hydrolase enzymes are composed of similar serine-histidine-aspartate catalytic triads.
- control reactions were defined as non-enzymatic reactions. Specifically, experiments conducted in the absence of a protein were defined as negative control reactions. Proteinaceous molecules such as bovine serum albumin and porcine ⁇ -globulins were used to study non-specific protein catalysis.
- the glass vials Prior to reaction, the glass vials were rinsed with acetone (x2) and ethanol (x2), dried, and silylated with hexamethyldisilazane (1 mmol) in the presence of acetic acid (0.2 mmol) for 30 m at 25 C. Subsequently, the vials were rinsed with ethanol (x2) and dried in an oven at 110 C. The silylated glass vials were confirmed not to contaminate the reactions with trimethylsilanol or hexamethyldisiloxane.
- the reactions were formulated with a 5:1 trimethylsilanol (225 mg) to protein (45 mg lipase, protease, or BSA) weight ratio in 1.3 mL toluene or 1.1 mL water.
- Toluene was dried over lithium aluminum hydride ('dry toluene', 11 ppm water) and hydrated with Milli-Q water ('wet toluene', 467 ppm water).
- Karl Fischer titrations were performed on an Aquatest IN titrator (Photovolt Corporation, New York, NY) to measure the water content in toluene.
- Milli-Q water ('water') was buffered with 50 mM Tris-HCl buffer, pH 7.0 ('buffered pH 7'). The estimated solubility of trimethylsilanol in water is 4.2% (i.e. 42.56 mg/mL). Based on the formulation, the two-phase reactions conducted in water were saturated with trimethylsilanol ( ⁇ 200 mg/mL). The closed (screw capped) reactions were conducted in inert glass vials at 25 C with magnetic stirring for 6 days. The reaction products were isolated and quantitatively analyzed by GC. Prior to analysis, the aqueous reactions were extracted (x2) with THF in the presence of NaCl and filtered through a Whatman Autovial® 5 0.45 ⁇ m Teflon® filter (#AV115NPUORG).
- Candida antarctica lipase Candida antarctica lipase
- Rhizomucor miehei lipase trypsin wheat germ lipase Candida antarctica lipase B was immobilized on acrylic resin beads (Novozyme® 435).
- protease enzymes were identified as target catalysts. Consequently, a series of serine-, cysteine-, aspartic-, and metallo-proteases were selected in order to evaluate their ability to catalyze the formation of a molecule with a siloxane bond in a neutral medium (pH 7.0) (Scheme 1). protease ⁇ Si - OH ⁇ Si - O - Si — H 2 0 buffered pH 7.0 25°C 3 hours trimethylsilanol hexamethyldisiloxane
- the glass vials Prior to reaction, the glass vials were silylated.
- the reactions were formulated with a 4:1 trimethylsilanol (80 mg) to protein (20 mg protease, BSA, or ⁇ -globulins) weight ratio ( ⁇ 1000:1 silanol to protease mole ratio) in 0.5 mL of 50 mM Tris-HCl buffered Milli-Q water, pH 7.0.
- Trimethylsilanol was chosen as a model silanol to study the role of an enzyme in the formation of molecules with a single siloxane bond. Notably, three sources of cathepsin L did not catalyze the condensation reaction. In contrast, although silicatein was documented to be highly homologous with cathepsin L, silicatein catalyzed the formation of particulate silica and silsesquioxanes.
- the activities of the enzymes depend upon the functionality of the non-natural organosilicon substrates. Substantial condensation of trimethylsilanol was not observed in the negative control, non-specific protein (i.e. BSA, ⁇ -globulins), small molecule (i.e. CaCl 2 , imidazole, N-methylimidazole), and polypeptide (i.e. poly-L-lysine) reactions in comparison to the raw material (FIG. 5).
- the small molecules were chosen to independently evaluate non-specific catalysis based on the functionality of catalytically active trypsin. Since calcium is required to maximize tryptic activity and stability, trypsin may be treated with calcium chloride.
- N- ⁇ - jc-tosyl-L-lysine chloromethyl ketone hydrochloride selectively and irreversibly inhibits trypsin activity without affecting ⁇ -chymotrypsin activity.
- TLCK inhibits trypsin by alkylating the histidine residue in the catalytic triad. After treating ⁇ -chymotrypsin with TLCK, the product yield significantly decreased in the replicate condensation experiment (FIG. 6).
- ⁇ -chymotrypsin did not catalyse the condensation of trimethylsilanol.
- trypsin treated with N-tosyl-L-phenylalanine chloromethyl ketone an irreversible chymotrypsin inhibitor, was used to complement the TLCK treated ⁇ -chymotrypsin experiment.
- TPCK inhibited chymotrypsin by alkylating the histidine residue in the catalytic triad. Based on the chromatographic results (FIG.
- trypsin as opposed to ⁇ -chymotrypsin was determined to catalyse the condensation of trimethylsilanol. Furthermore, the exceptional activity of trypsin and ⁇ -chymotrypsin observed in the original enzyme-catalysed condensation study (Table 2) was due to a tryptic impurity.
- a proteinaceous inhibition study was conducted to investigate the role of the enzymatic active site in the model silanol condensation reaction. Specifically, trypsin and ⁇ -chymotrypsin were inhibited with two distinctly different natural polypeptide inhibitors from soybean: a trypsin-chymotrypsin inhibitor (i.e. the Bowman-Birk Inhibitor, BBI) and a trypsin inhibitor from Glycine max (i.e. the Kunitz soybean trypsin inhibitor or Popcorn inhibitor, PCI).
- a trypsin-chymotrypsin inhibitor i.e. the Bowman-Birk Inhibitor, BBI
- Glycine max i.e. the Kunitz soybean trypsin inhibitor or Popcorn inhibitor, PCI
- the soybean inhibitors are highly stable proteins with well-defined inhibitory sites. Although the proteinaceous inhibitors originate from the same source, the amino acid sequences, tertiary structures, and properties of the polypeptides are different.
- BBI contains dual independent regions that selectively inhibit trypsin and chymotrypsin. The reactive sites within these regions are defined as Lysl6-Serl7 (trypsin) and Leu43-Ser44 (chymotrypsin). The kinetics and equilibria of the inhibition reactions are independent.
- PCI selectively inhibits trypsin through interactions with an Arg63-Ile64 reactive site.
- the enzymes Prior to reaction, the enzymes were inhibited with excess inhibitor (i.e. > 1:1 (w/w) or 4:1 BBI to protease and 2:1 PCI to protease mole ratios, respectively) in stirred neutral media (pH 7.0) for two hours before the addition of trimethylsilanol.
- the reactions were formulated with a 4:1 monomer to enzyme weight ratio ( ⁇ 1000:1 silanol to protease mole ratio) and conducted at 25 ° C for three hours.
- the reaction products were isolated and quantitatively analyzed by GC (FIG 7). Based on standard enzymatic activity assays, trypsin was fully inhibited with BBI
- trypsin appears to be catalytically active over a broad temperature range.
- the optimum temperature of the reaction was approximately 25 ° C.
- the rates of the trypsin-catalyzed condensation reactions decreased due to the degree of thermal denaturation.
- enzymatic reaction rates may increase with temperature, elevated temperatures have been reported to reversibly unfold and irreversibly inactivate enzymes including trypsin in water due to decomposition.
- N- ⁇ -benzoyl-L-arginine ethyl ester (BAEE) was used to study the activity of boiled tryptic solutions as a function of concentration in neutral media (pH 7.0). Different concentrations of trypsin (i.e. 2-40 mg/mL) were prepared in 0.5 mL of 50 mM Tris-HCl buffered Milli-Q water (pH 7.0). The solutions were boiled for 20 minutes before measuring the activity of the boiled trypsin by recording the change in absorbance at 253 nm due to the formation of N- ⁇ -benzoyl-L-arginine. The spectrophotometric activity data is illustrated in FIG. 9.
- the trypsin-catalyzed condensation of trimethylsilanol was studied over a 24-hour period at 25 ° C. Independent reactions were formulated with a 4:1 monomer to enzyme weight ratio (—1000:1 silanol to trypsin mole ratio) in a neutral medium (pH 7.0) and performed for defined periods of time over 24 hours. The trypsin-catalyzed condensation of trimethylsilanol was nearly complete after three hours at 25 ° C. Based on the stoichiometry of the condensation reaction, two moles of trimethylsilanol were consumed for each mole of hexamethyldisiloxane (HMDS) produced (mass balance, FIG , 10).
- HMDS hexamethyldisiloxane
- Equation 2 the experimental rate constant (IC R ) and the partial orders of reaction (i.e. ⁇ and ⁇ ) with respect to each reactant were defined.
- the overall order of reaction is the sum of the partial orders (i.e. ⁇ + ⁇ ). Since trypsin was not consumed during the condensation reaction (i.e. a catalyst), the term was included in the rate constant (k R ') and the theoretical rate equation (Equation 2) was simplified as defined in Equation 3.
- Equation 4 The general rate equation is depicted as Equation 4.
- the turnover number was treated as a relative value. Given a relative turnover number equal to 0.066 s "1 , the time period between each condensation reaction catalyzed by trypsin was calculated to be 15 s. In comparison to the maximum turnover numbers of other enzymes with their physiological substrates, the turnover number of the trypsin- catalyzed condensation of trimethylsilanol at 25 ° C was several orders of magnitude (i.e. ⁇ 10-10,000,000) slower than the cited values. For example, the turnover number of the trypsin-catalyzed condensation of trimethylsilanol was approximately 1500 times slower than a natural chymo trypsin-catalyzed hydrolysis reaction.
- the rate of trimethylsilanol condensation was studied as a function of the monomer to enzyme mole ratio.
- the mole ratios were formulated with a constant amount of trimethylsilanol (160 mg/mL) and a variable amount of trypsin (2-198 mg/mL) in buffered water (pH 7.0).
- the closed (screw capped) reactions were conducted at 25 C with magnetic stirring for three hours.
- the reaction products were isolated and quantitatively analyzed by GC (FIG. 11).
- the Michaelis-Menten kinetic values are relative, the large K m values indicate that the binding strength of the enzyme-substrate intermediate is weak. Comparatively, these K m values are several orders of magnitude (i.e. -1,000-25,000,000) larger than the K m values of other enzymes.
- the relative K m value of the trypsin-catalyzed condensation of trimethylsilanol at 25 C was approximately 1200 times larger than the chymotrypsin-catalyzed hydrolysis of acetyl-L-tryptophanamide.
- the fonnation of the trypsin-silanol intermediate appears to be the rate-limiting step in the condensation reaction. This is consistent with the fact that trypsin was not saturated with trimethylsilanol in aqueous media. Therefore, the rate of condensation or hydrolysis of the trypsin-silanol intermediate must be faster than the formation of the enzymatic intermediate.
- the trypsin-catalyzed condensation of trimethylsilanol was hypothesized to have a reaction mechanism (FIG. 13) similar to the proteolytic hydrolysis of amide and ester bonds. Activated and stabilized by the charge-relay system of the catalytic triad, the nucleophilic oxygen atom of serine was postulated to attack the electropositive silicon atom of trimethylsilanol. Equivalent to the acyl-enzyme complex, a silylated trypsin intermediate would form followed by the loss of water.
- the nitrogen atom of the histidine could form a stabilized pentacoordinate species with the silicon atom in the intermediate.
- the formation of the trypsin-silanol intermediate appears to be the rate-limiting step. This is consistent with the fact that organosilicon molecules are larger than analogous hydrocarbon tryptic substrates.
- the silylated trypsin intermediate may participate in either a condensation or hydrolysis reaction with trimethylsilanol or water leading to the formation of the hexamethyldisiloxane (product) or trimethylsilanol (reactant), respectively.
- trypsin Since trypsin was not saturated with trimethylsilanol in aqueous media, the rate of condensation or hydrolysis of the trypsin-silanol intermediate must be faster than the fonnation of the enzymatic intermediate. Regardless, trypsin would be recovered at the completion of either reaction.
- the profiles of the mammalian tryptic activities including the recombinant enzyme as a function of pH were similar.
- the mammalian source of bovine trypsin was observed to have the highest activity at pH 7.0.
- the optimum pH of Gadus morhua (i.e. Atlantic cod) trypsin appeared to be more acidic. Since calcium was required to achieve the maximum activity and stability of trypsin, the differences in the relative activities may be due to variable levels of calcium.
- the amount of calcium present in the commercial sources of trypsin was shown to be very different. Calcium activation of trypsin induces changes in the tertiary structure of the enzyme.
- calcium creates a compact structure due to increased helical content or an altered ⁇ -structure.
- the conformational changes have been hypothesized to be responsible for the documented increased enzymatic activity and thermal stability. Since the activity of trypsin is optimal in the presence of > 10 mM (ideally, 20 mM or 400 ppm) calcium, the decreased levels of calcium in porcine pancreas and recombinant bovine trypsin correlate with their activities in comparison with bovine pancreatic trypsin.
- bovine pancreatic trypsin to catalyze the trimethylsilanol condensation reaction was studied as a function of pH.
- the reactions were formulated with a 4:1 monomer to enzyme weight ratio (—1000:1 silanol to trypsin mole ratio) in aqueous media buffered from pH 4.0 to pH 10.0 and conducted at 25 ° C for three hours.
- the reaction products were isolated and quantitatively analyzed by GC (FIG. 15). Based on the chromatographic data, the enzyme-catalyzed condensation reaction was dependent on the pH.
- the silanol condensation reaction was optimum at pH 7.0. Comparatively, acid- and base-catalyzed silanol condensation was observed in the negative control reactions; primarily, at pH values less than 4 and greater than 10 (FIG. 15).
- trimethylsilanol In comparison to the natural pH activity profile (bovine trypsin, FIG. 16), trimethylsilanol partially inhibited (> 50%>) trypsin nearly immediately in basic buffered water (pH 7.5 to pH 9.0). Although trimethylsilanol did not inhibit trypsin in a neutral medium (pH 7.0), reactant inhibition increased by 50-65% with the basicity of the aqueous solution. Since trypsin was not denatured in the presence of trimethylsilanol, the inhibition of the hydrolysis (BAEE, FIG. 16) and condensation (trimethylsilanol, FIG. 15) reactions in basic media was hypothesized to be due to the silylation of other hydroxy- functional residues in the catalytic region.
- the alkoxysilane Prior to reaction, the alkoxysilane was pre-treated with sodium hydro gencarbonate due to the potential presence of residual chloro-functional silanes.
- the reactions were fo ⁇ nulated with a 4:1 trimethylethoxysilane to protein weight ratio (-1000:1 alkoxysilane to trypsin mole ratio) in neutral media (pH 7.0) and conducted at 25 C for three hours. Based on the estimated solubility of trimethylethoxysilane in water (1 mg/mL), the concentration of trimethylethoxysilane (-160 mg/mL) saturated the aqueous media and created two-phase reaction mixtures. The reaction products were isolated and quantitatively analyzed by GC (FIG. 17).
- the partial orders of the reactions with respect to reactants as well as the turnover numbers (k cat ) in the hydrolysis and condensation reactions were calculated. Since trypsin may not be saturated due to the limited solubility of trimethylethoxysilane in water, the turnover number was treated as a relative value. Given a relative turnover number equal to 0.53 s "1 , the time between each hydrolysis reaction catalyzed by trypsin was calculated to be approximately 2 s or 30 reactions per minute at IO C.
- the turnover number of the trypsin- catalyzed hydrolysis of trimethylethoxysilane at 10 ° C was approximately 200 times slower than a chymotrypsin-catalyzed hydrolysis reaction.
- the time period between a condensation reaction catalyzed by trypsin was calculated to be approximately 20 s or 3 reactions per minute at 10 C.
- the two-phase reactions were formulated with a 4:1 monomer to enzyme weight ratio (> 400:1 alkoxysilane to trypsin mole ratio) and conducted at 25 C for three hours.
- the reaction products were isolated and quantitatively analyzed by GC (FIG. 20). Comparatively, the glycol-functional silane appeared to be more miscible than trimethylhexoxysilane in water. Based on the chromatographic results, trypsin catalyzed the partial hydrolysis of trimethylhexoxysilane without condensation. Although the role of trypsin in the hydrolysis of the glycol-functional silane was not definitive, trypsin catalyzed the condensation of the product, trimethylsilanol.
- the relative rates of the different hydrolysis and condensation reactions during the three-hour reactions were unknown. Subsequently, four organo-functional alkoxysilanes were selected to study how the activity of trypsin varied as a result of different steric and electronic interactions with the substrate.
- the four organo-functional alkoxysilanes are phenyldimethylethoxysilane (PhMe 2 SiOEt), triphenylethoxysilane (Ph 3 SiOEt), 3-glycidoxypropyldimethylethoxysilane ((epoxy)Me 2 SiOEt), and aminopropyldimethylethoxysilane ((H 2 N(CH 2 ) 3 )Me 2 SiOEt).
- the two-phase reactions were formulated with a 4:1 monomer to enzyme weight ratio (> 300:1 alkoxysilane to trypsin mole ratio) and conducted at 25 C for three hours.
- the reaction products were isolated and quantitatively analyzed by GC (FIG. 21). Based on the chromatographic results, trypsin was observed to preferentially catalyze the hydrolysis and condensation of trimethylethoxysilane and 3- glycidoxypropyldimethylethoxysilane. Comparatively, phenyldimethylethoxysilane was hydrolysed but not condensed, while triphenylethoxysilane was neither hydrolysed nor condensed in the presence of trypsin.
- the cyclic siloxane is sterically larger than the cyclic alkoxysilane.
- the carbinol-functional silanol intermediate was hypothesized to be an acceptable substrate due to its ability to hydrogen bond with the aspartic acid residue within the binding domain of the catalytic region of trypsin.
- trypsin was observed to catalyze the polycondensation of tetraethoxysilane during the formation of a solid composite containing silica and trypsin.
- the role of the active site of trypsin in the polycondensation of tetraethoxysilane was not definitive in this study.
- trypsin was observed to selectively catalyze the hydrolysis and condensation of organo-functional alkoxysilanes under mild conditions.
- the reactions were formulated with a 4:1 monomer to enzyme weight ratio (-1000:1 trimethylethoxysilane to trypsin mole ratio) and conducted at 25 ° C for three hours.
- the reaction products were isolated and quantitatively analyzed by GC (FIG. 23).
- the treated enzymes were observed to catalyze the hydrolysis of trimethylethoxysilane, the condensation of trimethylsilanol was completely inhibited in comparison to the control reactions.
- the percent hydrolysis decreased in the presence of the BBI- (24%>) and PCI- (6%) inhibited trypsin. Following thermal denaturation, the activity of trypsin was comparable to the proteinaceous inhibition and previous denaturation experiments.
- trypsin from porcine pancreas i.e. mammalian
- Atlantic cod i.e. fish
- trypsin from bovine pancreas was greater than the alternate sources of trypsin including the recombinant enzyme in a neutral medium (pH 7.0).
- the inactivity of trypsin from the Atlantic cod appeared to be due to pH (FIG. 14). Since calcium was required to achieve the maximum activity and stability of trypsin, these observations may have been due to different optimum pH ranges and/or levels of calcium.
- trypsin was used as a catalyst in the polycondensation of a trifunctional alkoxysilane, methyltriethoxysilane, under mild conditions.
- the reaction was fommlated with a 4:1 methyltriethoxysilane (0.091 g, 511 ⁇ mol, 3.25 mmol Si) to trypsin (0.022 g, 0.9 ⁇ mol) weight ratio (-550 monomer to enzyme mole ratio) in a neutral medium (pH 7.0) and conducted at 25 C for seven days (Scheme 5).
- the solid and liquid reaction products were isolated and selectively characterized by infrared spectroscopy, microscopy, and mass specfrometry techniques. Based on the diffuse reflectance infrared Fourier transform spectra of trypsin and the solid reaction product, the isolated solid was determined to be a composite material containing a mixture of methylsilsesquioxane resin and trypsin. Comparatively, the spectral peaks of a methylsilsesquioxane resin were observed in the presence of a control spectrum acquired with trypsin.
- the symmetric methyl defonnation (MeSiO 3/2 , near 1270 cm “1 ), siloxane asymmetric stretch (SiOSi, near 1000-1130 cm “1 ), as well as the asymmetric methyl rock and silicon-carbon stretch (MeSiO 3/2 , near 778 cm “1 ) were observed in the presence of the spectral peaks associated with trypsin.
- the solid was observed to contain thick agglomerates ranging in size from approximately 200 ⁇ m to 1.5 mm.
- the rough surfaces of the agglomerate particles were composed of submicron round particles. Based on an energy dispersive spectroscopy (SEM-EDS) analysis, the surfaces of the particles were determined to contain silicon, oxygen, carbon, and sulfur.
- the liquid reaction products were isolated and characterized by electrospray ionisation mass specfrometry (ESI MS). Although methyltriethoxysilane was not observed in the spectral results, substantial hydrolysis and condensation of methyltriethoxysilane was not observed in the absence of trypsin. Primarily, ethoxy- functional low molecular weight oligomers (e.g. dimers, trimers, tetramers) and cyclic siloxanes were observed in the ESI MS spectrum. In comparison to the negative control reaction, trypsin promoted the complete hydrolysis and, subsequent, polycondensation of methyltriethoxysilane. The distributions of linear, cyclic, and branched siloxane molecules were fully hydroxylated. Although trypsin promoted the hydrolysis of the alkoxy- functional silicones, the role of the active site of trypsin in the polycondensation of these molecules was not definitive in this study.
- ESI MS electrospray ionisation mass
- cyclic siloxanes hexamethylcyclotrisiloxane, octamethylcyclotetrasiloxane, trimethyltri(trifluoropropyl)cyclotrisiloxane, tetramethyltetra(trifluoropropyl)cyclotetrasiloxane, and tetramethyltetraphenylcyclotetrasiloxane, were selected to study how the activity of trypsin varied as a result of different steric and electronic interactions with the substrate.
- the two-phase reactions were formulated with a 4:1 monomer to enzyme weight ratio and conducted at 25 C in neutral media (pH 7.0) for 8 days.
- the reaction products were isolated and qualitatively analyzed by GC (Table 5).
- the GC cyclic area percent values are qualitative Based on the chromatographic data, trypsin was not observed to catalyze the hydrolysis of the cyclic siloxane bonds. As previously reported, trypsin was unable to hydrolyze hexamethyldisiloxane in a neutral medium (pH 7.0) at 25 ° C. Since proteases will only interact with water-soluble substrates, the hydrolysis reactions would be severely hindered due to the immiscibility of the cyclic siloxanes in the aqueous phase. Although trypsin would theoretically catalyze of the hydrolysis of a siloxane bond due to the law of microscopic reversibility, the reverse reaction was not favored.
- Cutinase-catalyzed condensation of trimethylsilanol A model study was performed in which a mono-functional silane was chosen to focus on the formation of molecules with a single siloxane bond during the in vitro condensation of trimethylsilanol (Scheme 6).
- the biocatalyzed reactions were formulated with a 5:1 trimethylsilanol to protein weight ratio (i.e. -1,300:1 trimethylsilanol to cutinase mole ratio, 0.3 ⁇ mol cutinase) in 50 mM Tris-HCl buffered Milli-Q water (pH 7.0) at an -10:1 solvent to monomer weight ratio.
- the closed (screw capped) two-phase reactions were conducted in inert glass vials at 25°C with magnetic stirring for 14 hours. Specifically, the reactions were conducted in silylated glassware. Since a silanol- functional glass surface could react with trimethylsilanol, the silylated glassware was necessary to create an inert glass surface. Prior to analysis, the aqueous reactions were extracted with THF in the presence of NaCl and filtered through a Whatman Autovial® 5 0.45 ⁇ m Teflon® filter. The reaction products were quantitatively analyzed by gas chromatography- flame ionization detection (GC-FID) (FIG. 26).
- GC-FID gas chromatography- flame ionization detection
- control reactions were defined as non-enzymatic reactions.
- Experiments conducted in the absence of a protein were defined as negative control reactions.
- Proteinaceous molecules such as bovine serum albumin (BSA) and porcine- ⁇ - globulins (globulins) were used to study non-specific protein catalysis.
- BSA bovine serum albumin
- globulins porcine- ⁇ - globulins
- Substantial condensation of trimethylsilanol was not observed in the negative control and non-specific protein reactions in comparison to the raw material (trimethylsilanol, Me 3 SiOH).
- HMDS hexamethyldisiloxane
- the condensation reaction was conducted in water, the enzyme-catalyzed reaction was promoted by the phase separation of the product.
- the immiscibility of the product, hexamethyldisiloxane changed the equilibrium and promoted the condensation reaction in the presence of water. Since the aqueous medium was saturated with trimethylsilanol (i.e. a two-phase reaction mixture), the reactant would continue to enter the aqueous phase due to the dynamic equilibrium of the condensation reaction.
- DMDM Dimethyldimethoxysilane
- the mild reaction conditions i.e. low temperature, neutral pH
- the biocatalyzed reactions were initially formulated with an -10:1 alkoxysilane to cutinase weight ratio (i.e.
- volumetric efficiency was defined as the weight % monomer measured as a percentage of the total weight of the liquids in the reaction (i.e. DMDM + water).
- the closed (screw capped) two-phase reactions were conducted in inert glass vials at 25°C with magnetic stirring for 24 hours. Specifically, the reactions were conducted in silylated glassware.
- cutinase-catalyzed polycondensation reactions were replicated with an increased amount of enzyme (i.e. -500:1 DMDM to cutinase mole ratio, -20 ⁇ mol cutinase) over a longer period of time (5 days). Based on the degree of polycondensation obtained over an extended period of time (5 days vs. 24 hours) at two concentrations of enzyme (20 ⁇ mol vs. 5 ⁇ mol), cutinase was observed to catalyze the hydrolysis and condensation of DMDM (Table 7). Although the condensation reactions were conducted in water, the enzyme-catalyzed reactions were promoted by the phase separation of the products.
- enzyme i.e. -500:1 DMDM to cutinase mole ratio, -20 ⁇ mol cutinase
- alkoxysilane linear siloxane cyclic siloxane Scheme 7 Cutinase-catalyzed hydrolysis and condensation of dimethyldimethoxysilane.
- Diethyldiethoxygermane was chosen as an alternate substrate in order to investigate the ability of bovine pancreatic trypsin to catalyze the in vitro hydrolysis and condensation of an alkoxy- functional germanium molecule under mild conditions (Scheme 8).
- the mild reaction conditions i.e. low temperature, neutral pH
- the reactions were formulated with an -5:1 monomer to enzyme weight ratio (i.e.
- aqueous reactions Prior to analysis, the aqueous reactions were extracted with THF in the presence of NaCl and filtered through a Whatman Autovial® 5 0.45 ⁇ m Teflon® filter.
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/791,951 US7455998B2 (en) | 2004-03-03 | 2004-03-03 | Methods for forming structurally defined organic molecules |
| PCT/US2005/007240 WO2005085459A1 (en) | 2004-03-03 | 2005-03-03 | Methods for forming structurally defined organic molecules |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| EP1725669A1 true EP1725669A1 (en) | 2006-11-29 |
| EP1725669A4 EP1725669A4 (en) | 2009-04-29 |
| EP1725669B1 EP1725669B1 (en) | 2011-08-03 |
Family
ID=34911738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP05724727A Expired - Lifetime EP1725669B1 (en) | 2004-03-03 | 2005-03-03 | Method for producing organic molecules using hydrolases |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7455998B2 (en) |
| EP (1) | EP1725669B1 (en) |
| JP (2) | JP4987691B2 (en) |
| CN (1) | CN1946850B (en) |
| AT (1) | ATE518959T1 (en) |
| WO (1) | WO2005085459A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602006019940D1 (en) * | 2006-03-06 | 2011-03-17 | St Microelectronics Crolles 2 | Production of a shallow conducting channel made of SiGe |
| US8383755B2 (en) * | 2007-06-19 | 2013-02-26 | Brock University | Enzyme-medicated cross-linking of silicone polymers |
| WO2012036973A2 (en) * | 2010-09-15 | 2012-03-22 | Beeler, Nicole M. | Process for immobilization of candida antarctica lipase b |
| WO2012087676A2 (en) | 2010-12-23 | 2012-06-28 | Exxonmobil Research And Enginnering Company | Production of fatty acids and fatty acid derivatives by recombinant microorganisms expressing polypeptides having lipolytic activity |
| CN103014079B (en) * | 2012-12-28 | 2016-08-24 | 江南大学 | A kind of method applying to carry out Lipase absobed |
| SG11201900935RA (en) * | 2016-08-03 | 2019-02-27 | Shimadzu Corp | Method for preparing peptide fragments, method for preparing protease to be used therein, and kit for preparing peptide fragments |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990009446A1 (en) | 1989-02-17 | 1990-08-23 | Plant Genetic Systems N.V. | Cutinase |
| JPH0689148B2 (en) * | 1990-03-12 | 1994-11-09 | 日本電信電話株式会社 | Polymer manufacturing method |
| JPH06227944A (en) * | 1993-02-05 | 1994-08-16 | Kanebo Ltd | Cosmetic |
| JP3228040B2 (en) * | 1994-12-26 | 2001-11-12 | 信越化学工業株式会社 | Scratching agent for glass container and glass container |
| DE10037270B4 (en) * | 2000-07-28 | 2007-09-13 | Müller, Werner E. G., Prof. Dr. | Silicatein-mediated synthesis of amorphous silicates and siloxanes and their use |
| DE10046039A1 (en) | 2000-09-18 | 2002-03-28 | Basf Ag | Polycondensation of organic silicon compounds |
| US20030119156A1 (en) * | 2001-12-20 | 2003-06-26 | Sakkab Nabil Yaqub | Biosynthesis of cyclic siloxanes |
| AU2002357904A1 (en) | 2001-12-20 | 2003-07-09 | The Procter And Gamble Company | Biosynthesis of cyclic siloxanes |
| EP1539777B1 (en) | 2002-08-16 | 2012-06-06 | Dow Corning Corporation | Enzyme catalyzed organosilicon carbohydrates |
| DE10352433B4 (en) * | 2003-11-10 | 2012-10-11 | Nanotecmarin Gmbh | Polypeptide of a silicatein-ß from Suberites domuncula, nucleic acid coding therefor, their uses, vector comprising this nucleic acid and host cell expressing this polypeptide |
-
2004
- 2004-03-03 US US10/791,951 patent/US7455998B2/en not_active Expired - Fee Related
-
2005
- 2005-03-03 CN CN2005800129628A patent/CN1946850B/en not_active Expired - Fee Related
- 2005-03-03 WO PCT/US2005/007240 patent/WO2005085459A1/en not_active Ceased
- 2005-03-03 EP EP05724727A patent/EP1725669B1/en not_active Expired - Lifetime
- 2005-03-03 JP JP2007502058A patent/JP4987691B2/en not_active Expired - Fee Related
- 2005-03-03 AT AT05724727T patent/ATE518959T1/en not_active IP Right Cessation
-
2011
- 2011-05-02 JP JP2011103042A patent/JP2011172589A/en active Pending
Non-Patent Citations (4)
| Title |
|---|
| BRANDSTADT ET AL: "59th ACS Midland Section Fall Scientific Meeting" THE MIDLAND CHEMIST, vol. 40, no. 7, 2003, page 1,29,37, XP002518347 Retrieved from the Internet: URL:membership.acs.org/M/Midl/midchemist/i ssues/2003%20Oct%20MC.pdf> * |
| FUKUI ET AL: "Enzymatic preparation of optically active silylmethanol derivatives having a stereogenic silicon atom by hydrolase-catalyzed enantioselective esterification" TETRAHEDRON: ASYMMETRY, vol. 5, 1994, pages 73-82, XP002518348 * |
| KAWAMOTO ET AL: "Enzymatic conversion of organosilicon compounds in organic solvents" METHODS IN BIOTECHNOLOGY, vol. 15, 2001, pages 339-355, XP008103354 * |
| See also references of WO2005085459A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1946850A (en) | 2007-04-11 |
| ATE518959T1 (en) | 2011-08-15 |
| US20050196849A1 (en) | 2005-09-08 |
| EP1725669A4 (en) | 2009-04-29 |
| EP1725669B1 (en) | 2011-08-03 |
| US7455998B2 (en) | 2008-11-25 |
| WO2005085459A1 (en) | 2005-09-15 |
| JP2007525999A (en) | 2007-09-13 |
| JP4987691B2 (en) | 2012-07-25 |
| JP2011172589A (en) | 2011-09-08 |
| CN1946850B (en) | 2010-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bassindale et al. | Enzyme-catalysed siloxane bond formation | |
| Nawani et al. | Immobilization and stability studies of a lipase from thermophilic Bacillus sp: The effect of process parameters on immobilization of enzyme | |
| JP2011172589A (en) | Method for forming structurally defined organic molecule | |
| US8796000B2 (en) | Polyethersiloxane-coated enzyme preparations | |
| Fickers et al. | Production and down-stream processing of an extracellular lipase from the yeast Yarrowia lipolytica | |
| Li et al. | Conformation studies on Burkholderia cenocepacia lipase via resolution of racemic 1-phenylethanol in non-aqueous medium and its process optimization | |
| Soares et al. | Characterization of sol–gel encapsulated lipase using tetraethoxysilane as precursor | |
| Frampton et al. | Organosilicon biotechnology | |
| Oh et al. | Characterization of a novel esterase isolated from intertidal flat metagenome and its tertiary alcohols synthesis | |
| Yu et al. | Resolution of 2-octanol by SBA-15 immobilized Pseudomonas sp. lipase | |
| Secundo et al. | Activity and enantioselectivity of wildtype and lid mutated Candida rugosa lipase isoform 1 in organic solvents | |
| Brandstadt | Inspired by nature: an exploration of biocatalyzed siloxane bond formation and cleavage | |
| Brondani et al. | Synthetic Versatility of Lipases: Application for Si–O Bond Formation and Cleavage | |
| Divakar et al. | Purification, immobilization and kinetic characterization of GxSxG esterase with short chain fatty acid specificity from Lysinibacillus fusiformis AU01 | |
| Abbate et al. | Enzyme mediated silicon–oxygen bond formation; the use of Rhizopus oryzae lipase, lysozyme and phytase under mild conditions | |
| Abbate et al. | A large scale enzyme screen in the search for new methods of silicon–oxygen bond formation | |
| Murakami et al. | Characterization of polymer–enzyme complex as a novel biocatalyst for nonaqueous enzymology | |
| EP2018423B1 (en) | Method for extracting components from a yeast cell culture | |
| Frampton et al. | Biocatalysis in silicon chemistry | |
| Zherebtsov et al. | Identification of catalytically active groups in inulinase from Bacillus polymyxa 722 | |
| Maraite et al. | On the biocatalytic cleavage of silicon–oxygen bonds: A substrate structural approach to investigating the cleavage of protecting group silyl ethers by serine-triad hydrolases | |
| Tsai et al. | Enzymic properties of a mutant tryptophan synthase from Neurospora crassa | |
| Fishman et al. | Fatty-acid-modified enzymes as enantioselective catalysts in microaqueous organic media | |
| Frampton et al. | Enzyme-mediated synthesis of silsesquioxanes | |
| US5486598A (en) | Silica mediated synthesis of peptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20061003 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR |
|
| DAX | Request for extension of the european patent (deleted) | ||
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20090327 |
|
| 17Q | First examination report despatched |
Effective date: 20090623 |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: DOW CORNING CORPORATION |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Ref document number: 602005029305 Country of ref document: DE Free format text: PREVIOUS MAIN CLASS: C12P0001000000 Ipc: C12P0009000000 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: C12P 9/00 20060101AFI20110309BHEP |
|
| RTI1 | Title (correction) |
Free format text: METHOD FOR PRODUCING ORGANIC MOLECULES USING HYDROLASES |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602005029305 Country of ref document: DE Effective date: 20110929 |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20110803 |
|
| LTIE | Lt: invalidation of european patent or patent extension |
Effective date: 20110803 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110803 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110803 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111203 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110803 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111205 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110803 |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 518959 Country of ref document: AT Kind code of ref document: T Effective date: 20110803 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110803 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110803 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111104 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110803 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110803 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110803 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110803 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110803 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110803 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110803 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110803 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110803 |
|
| 26N | No opposition filed |
Effective date: 20120504 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602005029305 Country of ref document: DE Effective date: 20120504 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20120331 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20121130 |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20120331 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20120331 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20120303 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20120402 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111114 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111103 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20110803 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20120303 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20140226 Year of fee payment: 10 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20050303 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20140417 Year of fee payment: 10 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602005029305 Country of ref document: DE |
|
| GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20150303 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20151001 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150303 |
|
| P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230530 |